TAUNS Laboratories,Inc. FY2026 Q1 Earnings Report | IR Tracker

TAUNS Laboratories,Inc. FY2026 Q1 Earnings Report | IR Tracker

Financial Highlights

Net Sales: ¥2.37B
Operating Income: ¥547M
Net Income: ¥357M
EPS: ¥3.47

Income Statement

Item	Current	Prior	YoY %
Net Sales	¥2.37B	¥6.42B	-63.1%
Cost of Sales	¥738M	¥1.61B	-54.1%
Gross Profit	¥1.63B	¥4.81B	-66.1%
SG&A Expenses	¥1.08B	¥1.07B	+1.6%
Operating Income	¥547M	¥3.75B	-85.4%
Non-operating Income	¥9M	¥24M	-64.1%
Non-operating Expenses	¥51M	¥16M	+222.2%
Ordinary Income	¥505M	¥3.75B	-86.5%
Profit Before Tax	¥506M	¥3.76B	-86.5%
Income Tax Expense	¥148M	¥1.06B	-86.0%
Net Income	¥357M	¥2.70B	-86.8%
Interest Expense	¥51M	¥16M	+221.6%
Basic EPS	¥3.47	¥26.82	-87.1%
Diluted EPS	¥3.33	¥25.20	-86.8%
Dividend Per Share	¥6.00	¥6.00	+0.0%

Balance Sheet

Item	Current End	Prior End	Change
Current Assets	¥14.86B	¥15.48B	¥-613M
Cash and Deposits	¥4.61B	¥9.27B	¥-4.66B
Accounts Receivable	¥2.32B	¥248M	+¥2.07B
Inventories	¥3.87B	¥3.04B	+¥830M
Non-current Assets	¥24.22B	¥21.04B	+¥3.18B

Profitability Ratios

Item	Value
Net Profit Margin	15.1%
Gross Profit Margin	68.8%
Current Ratio	156.7%
Quick Ratio	115.8%
Debt-to-Equity Ratio	1.52x
Interest Coverage Ratio	10.78x
Effective Tax Rate	29.3%

Year-over-Year Comparison

Item	YoY Change
Net Sales YoY Change	-63.1%
Operating Income YoY Change	-85.4%
Ordinary Income YoY Change	-86.5%
Net Income YoY Change	-86.7%

Item	Value
Shares Outstanding (incl. Treasury)	103.21M shares
Average Shares Outstanding	103.18M shares
Book Value Per Share	¥150.35

Dividend Information

Item	Amount
Q2 Dividend	¥6.00
Year-End Dividend	¥22.00

Full Year Forecast

Item	Forecast
Net Sales Forecast	¥20.77B
Operating Income Forecast	¥8.32B
Ordinary Income Forecast	¥8.14B
Net Income Forecast	¥8.61B
Basic EPS Forecast	¥84.66
Dividend Per Share Forecast	¥14.00